Financials

  • Market Capitalization 14.7 M
  • Employee 524
  • Founded 2008
  • CEO Bahija Jallal
  • Website www.immunocore.com
  • Headquarter United Kingdom
  • FIGI BBG00YYCXFB9
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-48.89
주가매출액비율
4.37

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

뉴스